Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine.
about
Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccinesViral vector-based influenza vaccines.Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platform.Comparison of two high-throughput assays for quantification of adenovirus type 5 neutralizing antibodies in a population of donors in China.Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancerAn adenovirus-vectored nasal vaccine confers rapid and sustained protection against anthrax in a single-dose regimenThe generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic.A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patientsDecreased Vector Gene Expression from E2b Gene-Deleted Adenovirus Serotype 5 Vaccines Intensifies Proinflammatory Immune Responses.
P2860
Q27013568-404A4A26-2F10-464E-9926-3213885EEC52Q30390938-A3850981-5EDC-4B54-A1B7-DDC606E702C6Q30422006-E8999312-C9C3-4DA8-A0C5-E3A3AD348702Q34289005-75737D00-8934-49C5-A1E8-4F5CE9AF92AFQ34358402-872F8254-0E54-4502-AADC-58B4D40442CFQ35864700-1EB65770-21A9-4979-B700-8B0475A95D7FQ36504794-BDDD2A89-4B23-4536-A1F4-0C9A0A0FE388Q36544576-4ABD8D4D-C61A-4A51-B734-D2C69DF2986BQ37067254-2C38D0AC-C0B6-4DB2-AE19-05DA4FA8C208Q37068071-60602E99-0608-41ED-93EB-9849514E4532Q40256121-73598FCF-2479-42DA-A4CD-7C8944017180
P2860
Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prevention of influenza virus ...... NA adenovirus vector vaccine.
@ast
Prevention of influenza virus ...... NA adenovirus vector vaccine.
@en
type
label
Prevention of influenza virus ...... NA adenovirus vector vaccine.
@ast
Prevention of influenza virus ...... NA adenovirus vector vaccine.
@en
prefLabel
Prevention of influenza virus ...... NA adenovirus vector vaccine.
@ast
Prevention of influenza virus ...... NA adenovirus vector vaccine.
@en
P2093
P2860
P1433
P1476
Prevention of influenza virus ...... NA adenovirus vector vaccine.
@en
P2093
Aida Walker
Bi-Hung Peng
Elizabeth S Gabitzsch
Frank R Jones
Jeanon Smith
Jennifer Smith
Joseph P Balint
Magda Salazar
Slobodan Paessler
Viktoriya Borisevich
P2860
P304
P356
10.1016/J.VACCINE.2011.07.073
P407
P577
2011-08-05T00:00:00Z